Eli Lilly’s top dealmaker says don’t be surprised to see more M&A that pushes Lilly into new areas
0 5 mins 5 hrs

Eli Lilly’s top dealmaker says don’t be surprised to see more M&A that pushes Lilly into new areas

Jacob Van Naarden is busy.  In addition to running Eli Lilly‘s oncology business, he’s now responsible for finding the drugmaker’s next opportunities as head of business development. And Lilly, now the world’s largest pharmaceutical company, is hungrier than ever for deals.  “The company’s financial strength […]

Health